61 results about "Euphorbia acanthothamnos" patented technology

The invention discloses a botanical insecticide for fruit trees and a preparation method and an application thereof, and belongs to the technical field of insecticide preparation. The botanical insecticide for fruit trees comprises the following raw materials: scutellaria baicalensis, purslane, datura stramonium, pyrethrum, paulownia leaf, sophora alopecuroide, magnolia cortex, melia azedarach, wasabi, chinaberry bark, ash bark, sophora flavescens, euphorbia soongarica, anabasis aphylla, dioscorea zingiberensis, lettuce, mint, tripterygium wilfordii, salix babylonica leaf, Chinese prickly ash and water. The botanical insecticide for fruit trees is prepared by steps of medical liquid extraction, concentration, drying, crushing, sieving, sterilization and the like. The botanical insecticide for fruit trees has advantages of nontoxic component and no residue, is pollution-free, green and environmentally friendly, and will not cause environmental pollution. The botanical insecticide for fruit trees can effectively control plant insects such as citrus bud mite, Aonidiella aurantii, papilionoidea, tortrix and the like. One-time killing rate reaches 95.56% and above. The plant insects have no drug resistance and can be used for 4-6 years.

The invention discloses a novel pesticide, and a preparation method and an application thereof, and belongs to the technical field of preparation of pesticides. The novel pesticide comprises, by weight, leaves of Salix babylonica.L, Piper methysticum Forst, Camellia Sinensis leaf, Anabasis aphylla L., paulownia leaf, Derris fordii Oliv., garlic, neem, horseradish, Pterocarya stenoptera leaves, Cortex Fraxini, Sophora flavescens, Euphorbia soongarica, pyrethrum, onion, patrinia herb, purslane, Radix Scutellariae, aloe, Cortex Magnoliae Officinalis and water, and the novel pesticide is prepared through the steps of medicine solution extraction, concentration, drying, crushing, sieving and disinfection. The novel pesticide has the advantages of nontoxic component, no residue, no nuisance, simple production method, low cost and good application effect, can effectively prevent and treat yellow spiders, Parlatoria pergandii Comstock, papilios, leaf miner and other plant pests, has a primary killing rate reaching 96.06% or above, has no medicine resistance, and can be used for 4-6 years.

The invention relates to novel compositions comprising of an extract of the plant Euphorbia prostrata, particularly with pharmaceutically acceptable carrier(s) / base(s), optionally with additional therapeutic agent(s) useful for the treatment of anorectal disease and colonic diseases such as hemorrhoids, fissures, cracks, fistulas, abscesses, inflammatory bowel disease, and the like. The novel compositions possess properties to control inflammation, prevent capillary bleeding and fragility in mammalians, particularly human beings. Process for the preparation of such novel compositions comprising an extract of the plant Euphorbia prostrata and pharmaceutically acceptable carrier(s) / base(s) useful for the treatment of anorectal disease including hemorrhoids, and colonic diseases are also provided. The composition comprise of flavonoidal and phenolic constituents extracted from the plant Euphorbia prostrata that possess anti-inflammatory, analgesic, haemostatic and wound-healing properties.

The invention discloses an externally-used analgesic medicament, which is prepared from Kusnezoff monkshood root, shortstalk monkshood root, star aniseed, Eucalyptus globules leaf, notoginseng, Eriosema himalaicum Ohashi and drynaria by a predetermined weight proportions.

The invention discloses application of euphorbiaceous acid to biopesticides and particularly relates to application of the euphorbiaceous acid to resistance to rice blast of plants, plant anthracnose, speckled leaf blotch of plants and wheat snow mould leaf blight of plants. The euphorbiaceous acid provided by the invention is capable of effectively inhibiting various plant pathogens, and the selection range of biological-source antibacterial agents is broadened.

The invention discloses a Chinese medicinal preparation for controlling parasites of aquatic animal as well as a preparation method and application thereof. The Chinese medicinal preparation for controlling the external parasites of the aquatic animals is prepared by the following steps: (1) carrying out Soxhlet extraction on euphorbia fischeriana by using 80% ethanol and collecting an extracting solution; (2) extracting by using petroleum ether; (3) extracting by using ethyl acetate to obtain solid residues; (4) eluting the solid residues by using ethanol, and volatilizing a solvent to obtain an euphorbia fischeriana ethyl acetate extract; and (5) weighing 3-10g of the extract obtained in (4), dissolving the extract completely by using acetone, adding 5-10g of emulsifier and 1-2g of stabilizer, and fixing the volume to be 100ml by using acetone. The method can be used for separating active parasite-killing components of the euphorbia fischeriana, is feasible and is convenient to operate, the safety concentration of the euphorbia fischeriana extract to crucian and grass crap is 2.61ppm and 2.38ppm respectively, thus the Chinese medicinal preparation is relatively safe for fish, can be applied to control of the external parasites of the aquatic animals in aquaculture production and is suitable for meeting the requirements of intensified and large-scale aquaculture.

Oral pharmaceutical compositions comprising dry extract of Euphorbia prostrata from about 0.1% to about 99% by weight wherein the effective average particle size of the dry extract of Euphorbia prostrata is not more than about 500 microns with pharmaceutically acceptable excipient(s) and process(s) for the preparation of such compositions useful for the treatment of anorectal disease and colonic diseases such as hemorrhoids, fissures, cracks, fistulas, abscesses, inflammatory bowel disease and the like are provided. Further, the pharmaceutical compositions of the present invention provides for the administration of a therapeutically and / or prophylactically effective amount of the Euphorbia prostrata wherein the compositions possess properties to control inflammation, prevent capillary bleeding and fragility in mammalians, particularly human beings. Furthermore, the compositions preferably provides a release of not less than about 50% of the dry extract of Euphorbia prostrata in first 15 minutes and not less than about 80% of dry extract of Euphorbia prostrata after total dissolution study of about 60 minutes when tested in accordance with the dissolution method described herein employing physiological pH range of about 2 to about 7.5 optionally with surfactant(s). Preferably the compositions of the present invention are in the form of tablets, minitablets, powders, capsules, pellets, granules, beads, compacts and the like. The present invention also provides and prophylactic and / or therapeutic methods of using such compositions for the treatment of anorectal diseases including hemorrhoids and colonic diseases.

Oral pharmaceutical compositions comprising dry extract of Euphorbia prostrata from about 0.1% to about 99% by weight wherein the effective average particle size of the dry extract of Euphorbia prostrata is not more than about 500 microns with pharmaceutically acceptable excipient(s) and process(s) for the preparation of such compositions useful for the treatment of anorectal disease and colonic diseases such as hemorrhoids, fissures, cracks, fistulas, abscesses, inflammatory bowel disease and the like are provided. Further, the pharmaceutical compositions of the present invention provides for the administration of a therapeutically and / or prophylactically effective amount of the Euphorbia prostrata wherein the compositions possess properties to control inflammation, prevent capillary bleeding and fragility in mammalians, particularly human beings. Preferably the compositions of the present invention are in the form of tablets, minitablets, powders, capsules, pellets, granules, beads, compacts and the like. The present invention also provides prophylactic and / or therapeutic methods of using such compositions for the treatment of anorectal diseases including hemorrhoids and colonic diseases.

The invention belongs to the medical technical field, and specifically relates to a preparation method for ebracteolatain A and an application of the ebracteolatain A in preparation of a breast cancer medicine. An extracting process comprises the steps of extracting euphorbia fischeriana steud medical material powder by petroleum ether, ethyl acetate and n-butyl alcohol, and next, performing separation the abovementioned parts by a silica gel column chromatography. The preparation method is simple, quick and convenient, the reproducibility is high, and the extracting purity is high; in the obtained compound, a diphenylmethane compound has relatively high breast cancer cell viability resistance while 2, 4-dihydroxyl-6-methoxyl-3-methyl-1-acetyl benzene has no obvious breast cancer cell viability resistance; and therefore, the compound with the diphenylmethane mother nucleus can obviously suppress the breast cancer cell viability, and the compound has certain structure-function relationship.

The invention belongs to the field of organic chemistry, and in particular relates to a class of diterpenoid derivatives with high MDR reversal activity and applications thereof. The present invention extracts new diterpenoid derivatives from Euphorbia spp Meter. Among them, the reversal fold of compound 29 was as high as 911.94.